Search research articles
Contact Us
Filters
Showing results (41-50 of 138) with videos related to
Page
of 14
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 12, 2009
Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction
Jonathan D Finn, Daniel Hui, Harre D Downey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 19, 2009
Host and vector-dependent effects on the risk of germline transmission of AAV vectors
Patricia Favaro, Harre D Downey, J Shangzhen Zhou, et al.
Plos One
|
June 25, 2015
Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis
Caroline J Aalbers, Lisette Bevaart, Scott Loiler, et al.
Human Gene Therapy
|
August 21, 2004
Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector
Yi-Lin Liu, Federico Mingozzi, Sol M Rodriguéz-Colôn, et al.
Human Gene Therapy
|
November 11, 2014
Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade
Sang-oh Han, Songtao Li, Elizabeth D Brooks, et al.
Plos One
|
July 12, 2013
IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expression
Irene Gil-Fariña, Marianna Di Scala, Lucia Vanrell, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 17, 2023
Analysis of Adeno-Associated Virus Serotype 8 (AAV8)-antibody complexes using epitope mapping by molecular imprinting leads to the identification of Fab peptides that potentially evade AAV8 neutralisation
Elena Piletska, Philippe Veron, Bérangère Bertin, et al.
The Journal of Clinical Investigation
|
October 24, 2018
Exposure to wild-type AAV drives distinct capsid immunity profiles in humans
Klaudia Kuranda, Priscilla Jean-Alphonse, Christian Leborgne, et al.
Molecular Therapy. Methods & Clinical Development
|
October 26, 2019
Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle
Jérôme Poupiot, Helena Costa Verdera, Romain Hardet, et al.
Ebiomedicine
|
November 24, 2020
Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosides
Ferran Vila-Julià, Raquel Cabrera-Pérez, Yolanda Cámara, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 138) with videos related to
Sort By:
Page
of 14
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 12, 2009
Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction
Jonathan D Finn, Daniel Hui, Harre D Downey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 19, 2009
Host and vector-dependent effects on the risk of germline transmission of AAV vectors
Patricia Favaro, Harre D Downey, J Shangzhen Zhou, et al.
Plos One
|
June 25, 2015
Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis
Caroline J Aalbers, Lisette Bevaart, Scott Loiler, et al.
Human Gene Therapy
|
August 21, 2004
Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector
Yi-Lin Liu, Federico Mingozzi, Sol M Rodriguéz-Colôn, et al.
Human Gene Therapy
|
November 11, 2014
Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade
Sang-oh Han, Songtao Li, Elizabeth D Brooks, et al.
Plos One
|
July 12, 2013
IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expression
Irene Gil-Fariña, Marianna Di Scala, Lucia Vanrell, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 17, 2023
Analysis of Adeno-Associated Virus Serotype 8 (AAV8)-antibody complexes using epitope mapping by molecular imprinting leads to the identification of Fab peptides that potentially evade AAV8 neutralisation
Elena Piletska, Philippe Veron, Bérangère Bertin, et al.
The Journal of Clinical Investigation
|
October 24, 2018
Exposure to wild-type AAV drives distinct capsid immunity profiles in humans
Klaudia Kuranda, Priscilla Jean-Alphonse, Christian Leborgne, et al.
Molecular Therapy. Methods & Clinical Development
|
October 26, 2019
Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle
Jérôme Poupiot, Helena Costa Verdera, Romain Hardet, et al.
Ebiomedicine
|
November 24, 2020
Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosides
Ferran Vila-Julià, Raquel Cabrera-Pérez, Yolanda Cámara, et al.
Page
of 14